Morepen Laboratories Ltd.

₹115.95

+ 0.80 (0.69%)

04:01 pm - close price

BSE: MOREPENLAB

NSE: MOREPENLAB

Industry: Pharmaceuticals & Drugs

House: Morepen

Overview

Events:

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Ratios

Reported EPS

Bad: 2Current: 1.73Good: 5

❌

Adjusted EPS

Bad: 3Current: 1.73Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: 10.19Good: 20

🟡

Current Ratio

Bad: 1Current: 2.37Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 7.96Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 10.06Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 1.73Good: 5

❌

Adjusted EPS

Bad: 3Current: 1.73Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: 10.19Good: 20

🟡

Current Ratio

Bad: 1Current: 2.37Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 7.96Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 10.06Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Peer Comparison

Consolidated

Peer comparison with financial metrics
company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.02	14.85	26.44	19.78	47.84	47.84	16.00	2.82	2.31	0.05	45.61	0.61	36.73	29.07	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.31	16.19	32.46	24.43	96.91	96.91	30.00	4.12	2.76	0	142.17	0.54	61.36	51.99	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	9.88	11.83	13.53	9.92	48.02	48.02	13.00	3.44	2.50	0.01	97.04	1.00	25.47	19.45	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	7.37	26.76	16.55	10.86	63.92	63.92	38.00	1.13	0.75	1.76	8.46	0.68	66.03	43.86	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	11.81	19.69	13.66	9.73	50.10	50.10	1.00	1.27	0.91	0.43	16.09	1.21	17.39	13.62	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	8.03	11.69	17.11	12.34	50.25	50.25	8.00	1.79	1.34	0.20	15.43	0.65	24.97	16.85	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	16.12	27.11	16.95	12.42	116.64	116.64	18.00	1.90	1.42	0.26	16.82	1.30	19.83	15.71	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	7.00	12.69	19.93	12.98	46.34	46.34	1.00	1.07	0.74	0.37	4.62	0.54	43.29	29.32	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	6.64	9.93	7.91	5.04	60.34	60.34	4.00	1.81	1.15	0.20	14.31	1.32	21.60	14.33	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	13.44	18.29	13.43	10.43	192.54	192.54	53.00	2.55	1.86	0.12	18.86	1.29	27.54	23.18	6.85	26.10	0.64

Scroll horizontally to see more columns

Quarterly Results

In Rs. Cr.	2023-09	2023-12	2024-03	2024-06
Net Sales	421.77	444.55	423.07	455.22
Expenditure+	388.18	393.99	374.69	403.60
Other Income+	3.24	4.07	4.24	3.43
Operating Profit	33.59	50.57	48.38	51.62
Interest	0.46	2.17	0.80	1.15
Depreciation and Amortization	7.69	8.45	9.62	5.73
Profit Before Tax	28.68	44.02	41.74	48.17
Tax+	7.43	12.03	13.46	12.00
Net Profit	21.26	31.99	28.28	36.17

Profit & Loss

In Rs. Cr.	202203	202303	202403	202503	202603
Sales	154682.69	141753.00	169043.25	181157.58	180569.15
Operational Expenses+	141015.45	133799.69	153180.79	163750.55	168006.26
Operating Profit	13667.24	7953.31	15862.46	17407.03	12562.89
Other Income	2009.88	613.34	1397.08	1836.37	2131.41
OPM %	8.84	5.61	9.38	9.61	6.96
Depreciation and Amortisation	2764.25	2793.04	3346.95	2898.17	3643.47
Interest	242.61	198.08	371.02	834.29	1641.37
Profit Before Tax	12670.26	5575.53	13541.57	15510.94	11992.00
Tax	2776.75	1702.12	3888.57	3709.40	2440.50
Net Profit	10168.27	3867.52	9615.99	11802.04	9487.68

Balance Sheet

In Rs. Cr.	202203	202303	202403	202503	202603
Assets+	107005.27	111049.51	129320.51	177809.93	193612.01
Liabilities+	107005.27	111049.51	129320.51	177809.93	193612.01

Cash Flow Statement

In Rs. Cr.	202203	202303	202403	202503	202603
Cash from Operating Activity+	-6024.02	-9117.06	7337.46	3205.67	3264.20
Cash from Investing Activity	-3167.85	-4650.93	-8330.02	-32150.66	-12341.60
Cash from Financing Activity	6633.44	14354.31	520.49	29988.60	9739.77
Net Cash Flow	-2558.43	586.32	-472.07	1043.61	662.37
Opening Cash & Cash Equivalents	4138.69	1580.26	2166.58	1694.51	2738.12
Closing Cash & Cash Equivalents	1580.26	2166.58	1694.51	2738.12	3118.97

Shareholder Pattern

In %	JUN'26	MAR'26	DEC'25	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24
Promoters+	35.65	35.65	35.65	35.65	35.65	35.65	35.65	35.65	38.22	38.22
Public+	64.35	64.35	64.35	64.35	64.35	64.35	64.35	64.35	61.78	61.78
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	434912	447286	453137	461853	461180	468860	448361	430929	348766	336019

Corporate Actions

227 events in the last 3 years

Morepen Laboratories Ltd.

₹115.95

+ 0.80 (0.69%)

04:01 pm - close price

BSE: MOREPENLAB

NSE: MOREPENLAB

Industry: Pharmaceuticals & Drugs

House: Morepen

Overview

Peer Comparison

Consolidated

Peer comparison with financial metrics
company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.02	14.85	26.44	19.78	47.84	47.84	16.00	2.82	2.31	0.05	45.61	0.61	36.73	29.07	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.31	16.19	32.46	24.43	96.91	96.91	30.00	4.12	2.76	0	142.17	0.54	61.36	51.99	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	9.88	11.83	13.53	9.92	48.02	48.02	13.00	3.44	2.50	0.01	97.04	1.00	25.47	19.45	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	7.37	26.76	16.55	10.86	63.92	63.92	38.00	1.13	0.75	1.76	8.46	0.68	66.03	43.86	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	11.81	19.69	13.66	9.73	50.10	50.10	1.00	1.27	0.91	0.43	16.09	1.21	17.39	13.62	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	8.03	11.69	17.11	12.34	50.25	50.25	8.00	1.79	1.34	0.20	15.43	0.65	24.97	16.85	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	16.12	27.11	16.95	12.42	116.64	116.64	18.00	1.90	1.42	0.26	16.82	1.30	19.83	15.71	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	7.00	12.69	19.93	12.98	46.34	46.34	1.00	1.07	0.74	0.37	4.62	0.54	43.29	29.32	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	6.64	9.93	7.91	5.04	60.34	60.34	4.00	1.81	1.15	0.20	14.31	1.32	21.60	14.33	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	13.44	18.29	13.43	10.43	192.54	192.54	53.00	2.55	1.86	0.12	18.86	1.29	27.54	23.18	6.85	26.10	0.64

Scroll horizontally to see more columns

Quarterly Results

In Rs. Cr.	2023-09	2023-12	2024-03	2024-06
Net Sales	421.77	444.55	423.07	455.22
Expenditure+	388.18	393.99	374.69	403.60
Other Income+	3.24	4.07	4.24	3.43
Operating Profit	33.59	50.57	48.38	51.62
Interest	0.46	2.17	0.80	1.15
Depreciation and Amortization	7.69	8.45	9.62	5.73
Profit Before Tax	28.68	44.02	41.74	48.17
Tax+	7.43	12.03	13.46	12.00
Net Profit	21.26	31.99	28.28	36.17

Profit & Loss

In Rs. Cr.	202203	202303	202403	202503	202603
Sales	154682.69	141753.00	169043.25	181157.58	180569.15
Operational Expenses+	141015.45	133799.69	153180.79	163750.55	168006.26
Operating Profit	13667.24	7953.31	15862.46	17407.03	12562.89
Other Income	2009.88	613.34	1397.08	1836.37	2131.41
OPM %	8.84	5.61	9.38	9.61	6.96
Depreciation and Amortisation	2764.25	2793.04	3346.95	2898.17	3643.47
Interest	242.61	198.08	371.02	834.29	1641.37
Profit Before Tax	12670.26	5575.53	13541.57	15510.94	11992.00
Tax	2776.75	1702.12	3888.57	3709.40	2440.50
Net Profit	10168.27	3867.52	9615.99	11802.04	9487.68

Ratios

Reported EPS

Bad: 2Current: 1.73Good: 5

❌

Adjusted EPS

Bad: 3Current: 1.73Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: 10.19Good: 20

🟡

Current Ratio

Bad: 1Current: 2.37Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 7.96Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 10.06Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 1.73Good: 5

❌

Adjusted EPS

Bad: 3Current: 1.73Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: 10.19Good: 20

🟡

Current Ratio

Bad: 1Current: 2.37Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 7.96Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 10.06Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Cash Flow Statement

In Rs. Cr.	202203	202303	202403	202503	202603
Cash from Operating Activity+	-6024.02	-9117.06	7337.46	3205.67	3264.20
Cash from Investing Activity	-3167.85	-4650.93	-8330.02	-32150.66	-12341.60
Cash from Financing Activity	6633.44	14354.31	520.49	29988.60	9739.77
Net Cash Flow	-2558.43	586.32	-472.07	1043.61	662.37
Opening Cash & Cash Equivalents	4138.69	1580.26	2166.58	1694.51	2738.12
Closing Cash & Cash Equivalents	1580.26	2166.58	1694.51	2738.12	3118.97

Balance Sheet

In Rs. Cr.	202203	202303	202403	202503	202603
Assets+	107005.27	111049.51	129320.51	177809.93	193612.01
Liabilities+	107005.27	111049.51	129320.51	177809.93	193612.01

Corporate Actions

227 events in the last 3 years

Shareholder Pattern

In %	JUN'26	MAR'26	DEC'25	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24
Promoters+	35.65	35.65	35.65	35.65	35.65	35.65	35.65	35.65	38.22	38.22
Public+	64.35	64.35	64.35	64.35	64.35	64.35	64.35	64.35	61.78	61.78
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	434912	447286	453137	461853	461180	468860	448361	430929	348766	336019

Events:

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.